Your browser doesn't support javascript.
loading
Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2-A narrative review.
Masyeni, Sri; Iqhrammullah, Muhammad; Frediansyah, Andri; Nainu, Firzan; Tallei, Trina; Emran, Talha Bin; Ophinni, Youdiil; Dhama, Kuldeep; Harapan, Harapan.
Afiliación
  • Masyeni S; Department of Internal Medicine, Faculty of Medicine and Health Sciences, Universitas Warmadewa, Denpasar, Indonesia.
  • Iqhrammullah M; Department of Internal Medicine, Sanjiwani Hospital, Gianyar, Indonesia.
  • Frediansyah A; Graduate School of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Nainu F; National Research and Innovation Agency (BRIN), Wonosari, Indonesia.
  • Tallei T; Research Division for Natural Product Technology (BPTBA), Indonesian Institute of Sciences (LIPI), Wonosari, Indonesia.
  • Emran TB; Department of Pharmaceutical Biology, Pharmaceutical Institute, University of Tübingen, Tübingen, Germany.
  • Ophinni Y; Department of Pharmacy, Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia.
  • Dhama K; Department of Biology, Faculty of Mathematics and Natural Sciences, Sam Ratulangi University, Manado, Indonesia.
  • Harapan H; The University Centre of Excellence for Biotechnology and Conservation of Wallacea, Institute for Research and Community Services, Sam Ratulangi University, Manado, Indonesia.
J Med Virol ; 94(7): 3006-3016, 2022 07.
Article en En | MEDLINE | ID: mdl-35315098
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Med Virol Año: 2022 Tipo del documento: Article País de afiliación: Indonesia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Med Virol Año: 2022 Tipo del documento: Article País de afiliación: Indonesia